Xero Shares Rebound to A$69.83 as CEO Pay Fight Overshadows Gains

Xero shares rose 2.29% to A$69.83 on Thursday, clawing back only part of a selloff triggered by chief executive Sukhinder Singh Cassidy’s sale of her entire ordinary shareholding. The bounce has not settled nerves.

A A$2.19 million stock sale has been followed by a market hit worth many times that amount, and the mismatch is now feeding a fight over executive pay just weeks before Xero’s annual meeting. Layer in a broader market panic over artificial intelligence eating into subscription software, and the rebound looks thin.

Xero Claws Back to A$69.83 After a Rough Week

Xero Limited, the Wellington-based cloud accounting platform that trades on the Australian Securities Exchange (ASX) under the ticker XRO, recovered to A$69.83 in Thursday trading, up 2.29% on the day. The move claws back only part of what the stock lost days earlier.

Capital Brief reported Xero was one of the worst performers on the ASX 200 after it disclosed that Singh Cassidy had sold her entire direct shareholding, with shares down 4.3% to A$70.23 in afternoon trade that session. Rask Media and Proactive Investors separately clocked declines of 3% to 4% on the same news.

Xero reports its financial results in New Zealand dollars but trades in Australian dollars on the exchange. Capital Brief put the stock’s decline over the past 12 months at roughly 60%.

A $2.19 Million Sale Meets a Far Bigger Reaction

Singh Cassidy sold her remaining ordinary shares on market on July 7, an exchange filing showed. Xero disclosed the transaction six days later, on July 13, saying it was to manage personal tax obligations.

It was not her first sale this year. An earlier disposal in late May and early June included a mandatory tax-linked tranche, according to Proactive Investors.

• A$2.19 million: proceeds from Singh Cassidy’s July 7 sale of 29,608 shares at A$74 each.
• A$7.6 million: her combined share-sale proceeds since late May, across three separate transactions.
• Roughly A$875 million: the market-value slide across the sessions that followed, as tallied by the markets outlet TS2.tech.
• Zero: ordinary Xero shares Singh Cassidy now holds, though she retains restricted stock units and options.

The gap between a routine tax sale and an outsized market reaction suggests investors were not pricing mechanical selling pressure. They were reassessing how much they trust management’s alignment with the losses they had just absorbed.

The Options That Still Sit Underwater

The sale stung partly because Singh Cassidy no longer owns any ordinary Xero stock. She still holds 171,381 restricted stock units (RSUs) and 1,038,308 unlisted options, a stake that keeps her tied to the share price on paper.

None of those options carry value at current prices. Of the total, 463,308 carry a strike price of A$72.39 and 575,000 carry a strike of A$171.11. At Wednesday’s close of A$68.27, the smaller block needed roughly a 6% rise to reach its strike. The larger block needed about 151%.

Executive pay was already a sore point before the sale. Xero set Singh Cassidy’s target remuneration at US$15.2 million in late 2024, with at least 96% of it tied to performance or the share price. Xero chairman David Thodey said at the time the board was committed to “linking pay with performance.” Nearly half of shareholders were unconvinced: 48.74% of votes opposed the remuneration report at the August 2025 annual meeting.

There is a legitimate tension if the share price continues to fall and remuneration stays elevated.

Hailey Kim, a senior investment analyst at Wilson Asset Management, made that argument to the Australian Financial Review earlier this year. She told the paper this week she was not concerned about the tax-driven sale itself, but her earlier warning still frames the investor debate. Ron Shamgar, head of Australian equities at TAMIM Asset Management, was blunter, telling Capital Brief that Singh Cassidy is “not a CEO that we would back.”

What’s at Stake at Xero’s August 27 Annual Meeting?

Xero holds its annual meeting on August 27, its next test of investor patience on pay. Shareholders will vote again on the remuneration report, a year after nearly half of them rejected it.

Any sign the board is softening performance hurdles could reignite that backlash.

The date sits on Xero’s own investor calendar alongside half-year results due November 12 and full-year results scheduled for May 20, 2027, according to the company’s investor information and key reporting dates. Director nominations closed July 9, ahead of the meeting.

The board has room to recalibrate incentive structures before the vote. If it does not, and the share price keeps sliding while the pay target stays put, investors are likely to treat that as the board insulating its chief executive from losses they have already absorbed.

AI’s “SaaS Apocalypse” Keeps Investors on Edge

Xero’s governance questions are landing inside a bigger scare across software stocks. Investors have spent the year debating whether AI agents can replace the subscription tools small businesses have relied on for years.

The fear carries a price tag. Xero chief financial officer Claire Bramley said the sector lost more than $1 trillion in market value in one bruising week in February, in comments to CFO Brew, as fears spread that tools like Anthropic’s Claude Cowork could make traditional software obsolete. Xero’s own stock was down nearly 23% year to date by early March.

Separate research from Hardman & Co put the initial shock at closer to $285 billion wiped from SaaS valuations within 48 hours, tracing the panic to Anthropic’s Claude Codework demo, which showed AI agents handling financial analysis and project management. The two figures measure different windows, but they describe the same flight from software stocks.

Bramley argued the selloff had “nothing to do with near-term fundamentals,” pointing to revenue that was still growing 20% year over year at the time. Gartner has since put a number on how much is genuinely at risk, estimating that $234 billion in SaaS spending faces a reshuffle as agentic AI tools mature. CLSA has taken the opposite view, arguing the panic over an imminent SaaSpocalypse undersells the moats built into core accounting and compliance software.

Xero has responded with a mix of AI investment and internal discipline. It extended its partnership with Anthropic to weave Claude into its platform and put an early AI agent builder, XeroForce, into testing. It has also introduced an “Opt Out Program” offering voluntary severance to underperforming staff instead of a 30-day improvement plan, framed internally as raising execution standards for the AI era.

Revenue Climbed 31%, but the Market Wants Proof

The operating story undercuts some of the panic. Xero’s revenue grew 31% in its 2026 fiscal year and adjusted earnings before interest, tax, depreciation and amortization (EBITDA) rose 18%, even as net profit fell roughly 27% on integration costs tied to the Melio acquisition.

Xero added 110,000 customers in the United States during the year, helped by its integration of Melio, the bill-pay platform it bought for $2.5 billion. The board has also authorized a $550 million share buyback for the coming fiscal year to offset dilution from staff stock awards.

Analyst confidence has cooled this year, though several remain bullish. Fourteen analysts tracked by StockAnalysis.com rate the stock a Strong Buy on average, with a 12-month price target near A$129.66. RBC Capital upgraded Xero to Outperform from Sector Perform, arguing the recent selloff created an attractive risk-reward setup, though it trimmed its own target to A$155 from A$170. Goldman Sachs added the stock to its Asia-Pacific Conviction List.

Simply Wall St data shows the consensus fair value estimate cut to about A$82.74 from roughly A$109.01, still well above Thursday’s close. That gap between falling price targets and a rising business story is not unique to Xero. Guggenheim’s buy call on ServiceNow recently framed that stock as a valuation trade, a shift now facing other SaaS names once bought purely for growth.

XRO’s Chart Shows Buyers Defending A$68

The four-hour chart, as tracked on TradingView, tells a more cautious story than the day’s headline gain, with real-time moving-average and momentum readings still pointing to resistance overhead.

XRO is trading below nearly every major moving average, with the 10-period exponential moving average (EMA) near A$70.53 and the 10-period simple moving average around A$70.68 forming the first resistance zone.

Above that, the 20-period EMA near A$71.25, the 30-period EMA near A$71.63 and the Ichimoku base line near A$71.71 stack into a heavier band between A$71 and A$72. The 50-period EMA sits near A$72.46, the 100-period EMA at A$74.59, and the 200-period EMA waits much higher, near A$81.23.

The Hull Moving Average near A$68.83 is the only moving-average signal currently flashing buy. RSI sits at 43.55 and Stochastic %K near 20.19, both soft but not deeply oversold, while MACD reads sell and Momentum reads buy.

• First support at A$68.80, then A$68.00; a break below opens the door toward A$65.
• First resistance at A$70.50, the level buyers need to reclaim to build on Thursday’s bounce.
• A sustained move above A$72 would suggest the selloff is stabilizing.
• A break above A$74.60 would mark a stronger technical recovery signal.

Until XRO clears the A$71 to A$72 band, rallies are likely to keep meeting sellers.

Xero’s Recovery Now Waits on August 27

Thursday’s bounce shows some buyers stepping back in. Confidence remains thin.

Xero still runs a dominant cloud accounting franchise across Australia, New Zealand, the United Kingdom and North America, with revenue still climbing and an AI roadmap the company is counting on to strengthen its product. Governance and pay now sit at the center of the stock’s story, and shareholders get their next vote on both at the August 27 annual meeting. XRO still needs to clear A$72 before the rebound counts as more than a bounce.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Xero shares carry market risk, and the technical levels, analyst targets and price figures cited are accurate as of publication on July 16, 2026, and may change. Consult a licensed financial adviser before making investment decisions.